• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK SJM TRIFECTA VALVE
Device Problem Degraded (1153)
Patient Problem Insufficient Information (4580)
Event Date 01/01/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Attachment: article titled ¿ outcomes following initial multicenter experience with robotic aortic valve replacement: defining a path forward".
 
Event Description
The article, "outcomes following initial multicenter experience with robotic aortic valve replacement: defining a path forward", was reivewed.The article presented a prospective, multicenter study to report the initial 200 international cases performed, provide a status update on the progress of multicenter ravr adoption, and present recommendations on program development and training.Devices included in this study were trifecta valve, unknown mechanical valves, and unknown bioprosthetic valves.The article concluded that the present multicenter international experience highlights that in centers with established robotic experience, the ravr procedure is reproducible and safe with excellent early results.As more centers initiate ravr programs, a dedication to reproducible quality patient care remains paramount and the recommendations for team training provided in this report aims to assist this endeavor.[the primary and corresponding author was (b)(6), (b)(6) university, with corresponding email: (b)(6).The time frame of the study was from january 2020 to september 2023.A total of 212 patients were included in this study, of which only one was confirmed to have received an abbott device.The average age was 67 years and the average gender was male.Comorbidities included atrial fibrillation, hypertension, diabetes mellitus, peripheral artery disease, coronary artery disease, end stage renal disease, cerebrovascular accident, permanent pacemaker, regurgitation (mitral/tricuspid/aortic), severe aortic stenosis, unicuspid/bicuspid aortic valve.
 
Manufacturer Narrative
B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided summarized patient outcomes/complications of trifecta valve were reported in a research article in a subject population with multiple co-morbidities including atrial fibrillation, hypertension, diabetes mellitus, peripheral artery disease, coronary artery disease, end stage renal disease, cerebrovascular accident, permanent pacemaker, regurgitation (mitral/tricuspid/aortic), severe aortic stenosis, and unicuspid/bicuspid aortic valve.Some of the complications reported were surgical intervention, hospitalization, and structural valve deterioration; these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18699418
MDR Text Key336397658
Report Number2135147-2024-00645
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SJM TRIFECTA VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/14/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-